Comparative genomic analyses identify common molecular pathways modulated upon exposure to low doses of arsenic and cadmium

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Benton, Margaret A ^a   Rager, Julia E ^a   Smeester, Lisa ^a   Fry, Rebecca C ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENITE SODIUM; CADMIUM CHLORIDE; CYTOKERATIN 16; METAL; OCTAMER TRANSCRIPTION FACTOR 1; PROTEIN ST3GAL1; PROTEIN ZF5; SIALYLTRANSFERASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ARSENIC; CADMIUM; TRANSCRIPTION FACTOR;

ARTICLE; CARCINOGENESIS; COMPARATIVE GENE MAPPING; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC IDENTIFICATION; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; LYMPHOBLASTOID CELL; MOLECULAR BIOLOGY; MOLECULAR GENETICS; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; CELL LINE; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METHODOLOGY; PROTEIN ANALYSIS;

ARSENIC; CADMIUM; CELL LINE; COMPARATIVE GENOMIC HYBRIDIZATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN INTERACTION MAPPING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 79953249622     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-173     Document Type: Article

References (59)

1. Agency for Toxic S, Disease R Agency for Toxic Substances and Disease Registry (ATSDR), Priority List of Hazardous Substances 2007, Agency for Toxic S, Disease R.
2. Kapaj S, Peterson H, Liber K, Bhattacharya P. Human health effects from chronic arsenic poisoning--a review. J Environ Sci Health A Tox Hazard Subst Environ Eng 2006, 41(10):2399-2428.
3. Jarup L, Akesson A. Current status of cadmium as an environmental health problem. Toxicology and Applied Pharmacology 2009, 238:201-208. 10.1016/j.taap.2009.04.020, 19409405.
4. Iarc Beryllium, Cadmium, Mercury and Exposures in the Glass Manufacturing Industry. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. 1993, 58:444. Iarc.
5. Iarc IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, Suppl. 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42. 1987, Iarc.
6. Iarc IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Some Metals and Metallic Compounds. 1980, 23. Iarc.
7. Iarc Some drinking-water disinfectants and contaminants, including arsenic. 2004, 84:1-477. Iarc.
8. Huang C, Qingdong K, Costa M, Shi X. Molecular mechanisms of arsenic carcinogenesis. Molecular and cellular biochemistry 2004, 255(1-2):57. 10.1023/B:MCBI.0000007261.04684.78, 14971646.
9. Joseph P. Mechanisms of cadmium carcinogenesis. New Insights into the Mechanisms of Cadmium Toxicity - Advances in Cadmium Research 2009, 238(3):272-279.
10. Liao CM, Shen HH, Chen CL, Hsu LI, Lin TL, Chen SC, Chen CJ. Risk assessment of arsenic-induced internal cancer at long-term low dose exposure. J Hazard Mater 2009, 165(1-3):652-663. 10.1016/j.jhazmat.2008.10.095, 19062162.
11. Satarug S, Moore MR. Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ Health Perspect 2004, 112(10):1099-1103. 10.1289/ehp.6751, 1247384, 15238284.
12. Andrew AS, Warren AJ, Barchowsky A, Temple KA, Klei L, Soucy NV, O'Hara KA, Hamilton JW. Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environ Health Perspect 2003, 111(6):825-835. 1241504, 12760830.
13. Hester SD, Drobna Z, Andrews DMK, Liu J, Waalkes MP, Thomas DJ, Styblo M. Expression of AS3MT alters transcriptional profiles in human urothelial cells exposed to arsenite. Human and Experimental Toxicology 2009, 28(1):49-61. 10.1177/0960327109102368, 19411561.
14. Hu Y, Jin X, Snow ET. Effect of arsenic on transcription factor AP-1 and NF-kappaB DNA binding activity and related gene expression. Toxicol Lett 2002, 133(1):33-45. 10.1016/S0378-4274(02)00083-8, 12076508.
15. Zheng XH, Watts GS, Vaught S, Gandolfi AJ. Low-level arsenite induced gene expression in HEK293 cells. Toxicology 2003, 187(1):39-48. 10.1016/S0300-483X(03)00025-8, 12679051.
16. Yamada H, Koizumi S. DNA microarray analysis of human gene expression induced by a non-lethal dose of cadmium. Industrial health 2002, 40(2):159. 10.2486/indhealth.40.159, 12064557.
17. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(43):15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
18. Danaee H, Nelson HH, Liber H, Little JB, Kelsey KT. Low dose exposure to sodium arsenite synergistically interacts with UV radiation to induce mutations and alter DNA repair in human cells. Mutagenesis 2004, 19(2):143-148. 10.1093/mutage/geh010, 14981161.
19. Guillamet E, Creus A, Ponti J, Sabbioni E, Fortaner S, Marcos R. In vitro DNA damage by arsenic compounds in a human lymphoblastoid cell line (TK6) assessed by the alkaline Comet assay. Mutagenesis 2004, 19(2):129-135. 10.1093/mutage/geh005, 14981159.
20. Hickman MJ, Samson LD. Apoptotic signaling in response to a single type of DNA lesion, O(6)-methylguanine. Mol Cell 2004, 14(1):105-116. 10.1016/S1097-2765(04)00162-5, 15068807.
21. Hornhardt S, Gomolka M, Walsh L, Jung T. Comparative investigations of sodium arsenite, arsenic trioxide and cadmium sulphate in combination with gamma-radiation on apoptosis, micronuclei induction and DNA damage in a human lymphoblastoid cell line. Mutat Res 2006, 600(1-2):165-176. 10.1016/j.mrfmmm.2006.04.002, 16764896.
22. Tapio S, Danescu-Mayer J, Asmuss M, Posch A, Gomolka M, Hornhardt S. Combined effects of gamma radiation and arsenite on the proteome of human TK6 lymphoblastoid cells. Mutat Res 2005, 581(1-2):141-152.
23. Oesch S, Gertsch J. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?. J Pharm Pharmacol 2009, 61(7):839-853.
24. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?. The Lancet 2001, 357(9255):539-545.
25. Fujiwaki R, Iida K, Nakayama K, Kanasaki H, Hata K, Katabuchi H, Okamura H, Miyazaki K. Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma. Gynecologic oncology 2003, 89(1):77-83. 10.1016/S0090-8258(02)00154-3, 12694657.
26. Argos M, Kibriya MG, Parvez F, Jasmine F, Rakibuz-Zaman M, Ahsan H. Gene Expression Profiles in Peripheral Lymphocytes by Arsenic Exposure and Skin Lesion Status in a Bangladeshi Population. Cancer Epidemiology Biomarkers & Prevention 2006, 15(7):1367-1375.
27. Dangi-Garimella S, Yun J, Eves EM, Newman M, Erkeland SJ, Hammond SM, Minn AJ, Rosner MR. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J 2009, 28(4):347-358. 10.1038/emboj.2008.294, 2646152, 19153603.
28. Cunha IW, Carvalho KC, Martins WK, Marques SM, Muto NH, Falzoni R, Rocha RM, Jr SA, Simoes ACQ, Fahham L, et al. Identification of Genes Associated with Local Aggressiveness and Metastatic Behavior in Soft Tissue Tumors. Translational Oncology 2010, 3:23-32. 2822450, 20165692.
29. Wicki R, Franz C, Scholl FA, Heizmann CW, Schäfer BW. Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell calcium 1997, 22(4):243-254. 10.1016/S0143-4160(97)90063-4, 9481475.
30. Lee SW, Tomasetto C, Swisshelm K, Keyomarsi K, Sager R. Down-regulation of a member of the S 100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(6):2504-2508. 10.1073/pnas.89.6.2504, 48687, 1372446.
31. Almadori G, Bussu F, Galli J, Rigante M, Lauriola L, Michetti F, Maggiano N, Schafer BW, Heizmann CW, Ranelletti FO, et al. Diminished expression of S100A2, a putative tumour suppressor, is an independent predictive factor of neck node relapse in laryngeal squamous cell carcinoma. J Otolaryngol Head Neck Surg 2009, 38(1):16-22.
32. Bulk E, Sargin B, Krug U, Hascher A, Jun Y, Knop M, Kerkhoff C, Gerke V, Liersch R, Mesters RM, et al. S100A2 induces metastasis in non-small cell lung cancer. Clin Cancer Res 2009, 15(1):22-29. 10.1158/1078-0432.CCR-08-0953, 19118029.
33. Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa MM-AE, Prieto J, Qian C. Blockade of Wnt Signaling Inhibits Angiogenesis and Tumor Growth in Hepatocellular Carcinoma. Cancer Research 2009, 69(17):6951-6959. 10.1158/0008-5472.CAN-09-0541, 19690140.
34. Han XXAS. Secreted Frizzled-related Protein 1 (SFRP1) Protects Fibroblasts from Ceramide-induced Apoptosis. The Journal of Biological Chemistry 2004, 279(4):2832-2840. 10.1074/jbc.M308102200, 14581477.
35. Hanson ML, Brundage KM, Schafer R, Tou JC, Barnett JB. Prenatal cadmium exposure dysregulates sonic hedgehog and Wnt/beta-catenin signaling in the thymus resulting in altered thymocyte development. Toxicol Appl Pharmacol 242(2):136-145. 10.1016/j.taap.2009.09.023, 2789900, 19818801.
36. Videira PA, Ligeiro D, Correia M, Trindade H. Gene expression analysis in superficial bladder cancer: comparison of two suitable endogenous reference genes. Curr Urol 2007, 1:145-150.
37. Wang P-H, Lee W-L, Juang C-M, Yang Y-H, Lo W-H, Lai C-R, Hsieh S-L, Yuan C-C. Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecologic oncology 2005, 99(3):631-639. 10.1016/j.ygyno.2005.07.016, 16112178.
38. Burchell J, Poulsom R, Hanby A, Whitehouse C, Cooper L, Clausen H, Miles D, Taylor-Papadimitriou J. An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology 1999, 9:1307-1311. 10.1093/glycob/9.12.1307, 10561455.
39. Kudo T, Ikehara Y, Togayachi A, Morozumi K, Watanabe M, Nakamura M, Nishihara S, Narimatsu H. Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Laboratory investigation; a journal of technical methods and pathology 1998, 78(7):797-811.
40. Schneider F, Kemmner W, Haensch W, Franke G, Gretschel S, Karsten U, Schlag PM. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1, 3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res 2001, 61:4605-4611.
41. Zhang T, Woods TL, Elder JT. Differential Responses of S100A2 to Oxidative Stress and Increased Intracellular Calcium in Normal, Immortalized, and Malignant Human Keratinocytes. 2002, 119(5):1196-1201.
42. Enk CD, Jacob-Hirsch J, Gal H, Verbovetski I, Amariglio N, Mevorach D, Ingber A, Givol D, Rechavi G, Hochberg M. The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes. Oncogene 2006, 25(18):2601-2614. 10.1038/sj.onc.1209292, 16434974.
43. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Radical Biology and Medicine 2000, 28(3):463-499. 10.1016/S0891-5849(99)00242-7, 10699758.
44. MSigDB Molecular Signatures Database. , http://www.broadinstitute.org/gsea/msigdb/index.jsp
45. Iaquinta PJ, Lees JA. Life and death decisions by the E2F transcription factors. Cell differentiation/Cell division, growth and death 2007, 19(6):649-657.
46. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD, Helin K. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 2001, 15(3):267-285. 10.1101/gad.864201, 312619, 11159908.
47. Zhao H, Jin S, Fan F, Fan W, Tong T, Zhan Q. Activation of the transcription factor Oct-1 in response to DNA damage. Cancer Res 2000, 60(22):6276-6280.
48. Oswald F, Liptay S, Adler G, Schmid RM. NF-kappa B2 Is a Putative Target Gene of Activated Notch-1 via RBP-Jkappa. Molecular and cellular biology 1998, 18(4):2077-2088. 121438, 9528780.
49. Tapias A, Ciudad CJ, Roninson IB, Noe V. Regulation of Sp1 by cell cycle related proteins. Cell cycle (Georgetown, Tex) 2008, 7(18):2856-2867. 10.4161/cc.7.18.6671, 2810142, 18769160.
50. Larsson L, Johansson P, Jansson A, Donati M, Rymo L, Berglundh T. The Sp1 transcription factor binds to the G-allele of the -1087 IL-10 gene polymorphism and enhances transcriptional activation. Genes Immun 2009, 10(3):280-284. 10.1038/gene.2008.79, 18843277.
51. Olofsson BA, Kelly CM, Kim J, Hornsby SM, Azizkhan-Clifford J. Phosphorylation of Sp1 in Response to DNA Damage by Ataxia Telangiectasia-Mutated Kinase. Molecular Cancer Research 2007, 5(12):1319-1330. 10.1158/1541-7786.MCR-07-0374, 18171990.
52. Takami Y, Russell MB, Gao C, Mi Z, Guo H, Mantyh CR, Kuo PC. Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells. Surgery 2007, 142(2):163-169. 10.1016/j.surg.2007.02.015, 2174430, 17689681.
53. Li JN, Mahmoud MA, Han WF, Ripple M, Pizer ES. Sterol Regulatory Element-Binding Protein-1 Participates in the Regulation of Fatty Acid Synthase Expression in Colorectal Neoplasia. Experimental cell research 2000, 261(1):159-165. 10.1006/excr.2000.5054, 11082286.
54. Yang Y, Morin PJ, Han WF, Chen T, Bornman DM, Gabrielson EW, Pizer ES. Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. Experimental cell research 2003, 282(2):132-137. 10.1016/S0014-4827(02)00023-X, 12531699.
55. Fry RC, Navasumrit P, Valiathan C, Svensson JP, Hogan BJ, Luo M, Bhattacharya S, Kandjanapa K, Soontararuks S, Nookabkaew S, et al. Activation of Inflammation/NF-kB Signaling in Infants Born to Arsenic-Exposed Mothers. PLoS Genet 2007, 3(11):e207. 10.1371/journal.pgen.0030207, 2082467, 18039032.
56. Kim MM, Wiederschain D, Kennedy D, Hansen E, Yuan ZM. Modulation of p53 and MDM2 activity by novel interaction with Ras-GAP binding proteins (G3BP). Oncogene 2007, 26(29):4209-4215. 10.1038/sj.onc.1210212, 17297477.
57. Jin YH, Dunlap PE, McBride SJ, Al-Refai H, Bushel PR, Freedman JH. Global Transcriptome and Deletome Profiles of Yeast Exposed to Transition Metals. PLoS Genet 2008, 4(4):e1000053. 10.1371/journal.pgen.1000053, 2278374, 18437200.
58. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4(2):249-264. 10.1093/biostatistics/4.2.249, 12925520.
59. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 2007, 23(23):3251-3253. 10.1093/bioinformatics/btm369, 17644558.